<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-08689</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0005027</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cell Biology/Cell Growth and Division</subject><subject>Genetics and Genomics/Gene Expression</subject><subject>Cardiovascular Disorders/Coronary Artery Disease</subject></subj-group></article-categories><title-group><article-title><italic>INK4/ARF</italic> Transcript Expression Is Associated with Chromosome 9p21 Variants Linked to Atherosclerosis</article-title><alt-title alt-title-type="running-head"><italic>INK4/ARF</italic> and Atherosclerosis</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sanoff</surname><given-names>Hanna K.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cho</surname><given-names>Hyunsoon</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Burd</surname><given-names>Christin E.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Torrice</surname><given-names>Chad</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mohlke</surname><given-names>Karen L.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ibrahim</surname><given-names>Joseph G.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Thomas</surname><given-names>Nancy E.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sharpless</surname><given-names>Norman E.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Genetics, The Lineberger Comprehensive Cancer Center, The University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Medicine, The Lineberger Comprehensive Cancer Center, The University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Department of Biostastisitcs, The Lineberger Comprehensive Cancer Center, The University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Department of Dermatology, The Lineberger Comprehensive Cancer Center, The University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Blagosklonny</surname><given-names>Mikhail V.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Ordway Research Institute, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>nes@med.unc.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: YL HS NS. Performed the experiments: YL CT. Analyzed the data: YL HS HC CT JGI NT NS. Contributed reagents/materials/analysis tools: YL HS CB. Wrote the paper: YL HS HC KM JGI NT NS.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>3</day><month>4</month><year>2009</year></pub-date><volume>4</volume><issue>4</issue><elocation-id>e5027</elocation-id><history><date date-type="received"><day>13</day><month>2</month><year>2009</year></date><date date-type="accepted"><day>23</day><month>2</month><year>2009</year></date></history><copyright-statement>Liu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2009</copyright-year><abstract><sec><title>Background</title><p>Genome-wide association studies (GWAS) have linked common single nucleotide polymorphisms (SNPs) on chromosome 9p21 near the <italic>INK4/ARF</italic> (<italic>CDKN2A/B</italic>) tumor suppressor locus with risk of atherosclerotic diseases and type 2 diabetes mellitus. To explore the mechanism of this association, we investigated whether expression of proximate transcripts (<italic>p16<sup>INK4a</sup></italic>, <italic>p15<sup>INK4b</sup></italic>, <italic>ARF</italic>, <italic>ANRIL</italic> and <italic>MTAP</italic>) correlate with genotype of representative 9p21 SNPs.</p></sec><sec><title>Methodology/Principal Findings</title><p>We analyzed expression of 9p21 transcripts in purified peripheral blood T-cells (PBTL) from 170 healthy donors. Samples were genotyped for six selected disease-related SNPs spanning the <italic>INK4/ARF</italic> locus. Correlations among these variables were determined by univariate and multivariate analysis. Significantly reduced expression of all <italic>INK4/ARF</italic> transcripts (<italic>p15<sup>INK4b</sup></italic>, <italic>p16<sup>INK4a</sup></italic>, <italic>ARF</italic> and <italic>ANRIL</italic>) was found in PBTL of individuals harboring a common SNP (rs10757278) associated with increased risk of coronary artery disease, stroke and aortic aneurysm. Expression of <italic>MTAP</italic> was not influenced by rs10757278 genotype. No association of any these transcripts was noted with five other tested 9p21 SNPs.</p></sec><sec><title>Conclusions/Significance</title><p>Genotypes of rs10757278 linked to increased risk of atherosclerotic diseases are also associated with decreased expression in PBTL of the <italic>INK4/ARF</italic> locus, which encodes three related anti-proliferative transcripts of known importance in tumor suppression and aging.</p></sec></abstract><counts><page-count count="5"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Recent human genome-wide association studies (GWAS) have shown that SNPs with high minor allele frequencies near the <italic>INK4/ARF</italic> (<italic>CDKN2A/B</italic>) tumor suppressor locus on chromosome 9p21 correlate with risk of atherosclerotic diseases (coronary artery disease (CAD) <xref ref-type="bibr" rid="pone.0005027-Helgadottir1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-McPherson1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-The1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Samani1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Broadbent1">&#x0005b;5&#x0005d;</xref>, ischemic stroke <xref ref-type="bibr" rid="pone.0005027-Helgadottir2">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Matarin1">&#x0005b;7&#x0005d;</xref>, and abdominal aortic aneurysm<xref ref-type="bibr" rid="pone.0005027-Helgadottir2">&#x0005b;6&#x0005d;</xref>) and type 2 diabetes mellitus (T2DM) <xref ref-type="bibr" rid="pone.0005027-Scott1">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Saxena1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Zeggini1">&#x0005b;10&#x0005d;</xref>. Evidence from our lab has suggested that expression of p16<sup>INK4a</sup>, one of the proteins encoded by the <italic>INK4/ARF</italic> locus, controls pancreatic islet proliferation and mass with aging <xref ref-type="bibr" rid="pone.0005027-Krishnamurthy1">&#x0005b;11&#x0005d;</xref>, and therefore could plausibly explain the link to T2DM. The mechanism underlying the association of these SNPs with atherosclerotic diseases, however, is less clear.</p><p>In particular, it is not known if these genetic variants are associated with altered expression of cis-encoded transcripts. The most replicated SNPs associated with strongest effect sizes for atherosclerotic disease and T2DM are &#x0003e;100 kb centromeric to the <italic>INK4/ARF</italic> locus (<xref ref-type="fig" rid="pone-0005027-g001">Fig. 1</xref>), which encodes three cell cycle inhibitors (p15<sup>INK4b</sup>, p16<sup>INK4a</sup>, ARF, reviewed in <xref ref-type="bibr" rid="pone.0005027-Kim1">&#x0005b;12&#x0005d;</xref>) and a recently discovered putative non-coding RNA designated <italic>ANRIL</italic><xref ref-type="bibr" rid="pone.0005027-Pasmant1">&#x0005b;13&#x0005d;</xref>. There are no known cis-regulatory elements of the <italic>INK4/ARF</italic> locus located at such a distance from the locus. It has also been suggested that a more distant gene on 9p21, <italic>MTAP</italic> (<xref ref-type="fig" rid="pone-0005027-g001">Fig. 1</xref>), could mediate disease associations <xref ref-type="bibr" rid="pone.0005027-The1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Samani1">&#x0005b;4&#x0005d;</xref>.</p><fig id="pone-0005027-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005027.g001</object-id><label>Figure 1</label><caption><title>The human <italic>INK4/ARF</italic> locus and CAD associated SNPs.</title><p>(I) <italic>INK4/ARF</italic>-associated transcripts and tested SNPs are shown as well as the location of <italic>MTAP</italic>, another gene at 9p21. Blue colored boxes indicate exons 2 and 3 shared by <italic>p16<sup>INK4a</sup></italic> and <italic>ARF</italic>. The location of 9p21 SNPs (II) and linkage disequilibrium (LD) coefficient values (III) from HapMap<xref ref-type="bibr" rid="pone.0005027-The2">&#x0005b;42&#x0005d;</xref> CEU (Utah residents with ancestry from northern and western Europe) are shown. The LD plot of D&#x02032;/LOD was generated using Haploview software <xref ref-type="bibr" rid="pone.0005027-The2">&#x0005b;42&#x0005d;</xref>. The strength of LD increases from white to blue to red: white (disequilibrium coefficient (D&#x02032;) &#x0003c;1 and LOD score &#x0003c;2); blue (D&#x02032;&#x0200a;&#x0003d;&#x0200a;1 and LOD score &#x0003c;2); pink (D&#x02032;&#x0003c;1 and LOD score &#x02265;2); and bright red (D&#x02032;&#x0200a;&#x0003d;&#x0200a;1 and LOD score &#x02265;2). (IV) The correlations with CAD and other age-associated conditions of the indicated SNPs are indicated by corresponding colors.</p></caption><graphic xlink:href="pone.0005027.g001"/></fig><p>In this work, we sought to determine whether there is a link between these disease-associated SNPs and expression of 9p21 transcripts. We found that individuals harboring a common SNP genotype associated with increased risk for atherosclerotic disease demonstrated markedly reduced expression of <italic>INK4/ARF</italic>-encoded transcripts in peripheral blood T-cells (PBTL), indicating a potentially important role for cell cycle inhibitors in atherosclerotic disease.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Ethics Statement</title><p>This study was approved by the University of North Carolina Institutional Review Board with all participants providing informed written consent.</p></sec><sec id="s2b"><title>Subjects, mRNA analysis and SNP genotyping</title><p>The subject characteristics will be described elsewhere in details (YL and NES, submitted). In brief, PBTLs were obtained from 170 healthy subjects and isolated to &#x0003e;90&#x00025; purity by Magnetic Activated Cell Sorting (MACS). MACS, RNA preparation and transcript expression analysis were performed in PBTL as described (<xref ref-type="bibr" rid="pone.0005027-Shields1">&#x0005b;14&#x0005d;</xref>, and YL and NES, submitted). Transcript expression levels are presented as log<sub>2</sub>-transformed expression (&#x00394;&#x00394;C<sub>T</sub>, ref. <xref ref-type="bibr" rid="pone.0005027-Livak1">&#x0005b;15&#x0005d;</xref>). Genomic DNA was prepared from buffy coats using Puregene Blood Core Kit (Qiagen) according to manufacture's instructions. All SNP genotyping was performed at the UNC Mammalian Genotyping Core using Taqman&#x000ae; SNP Genotyping assays by automatic genotype calling. Allele frequencies and linkage disequilibrium (LD) in studied subjects were comparable to those from HapMap (<xref ref-type="supplementary-material" rid="pone.0005027.s001">Table S1</xref>). All SNP genotypes were in Hardy-Weinberg Equilibrium (HWE) determined by Haploview software.</p></sec><sec id="s2c"><title>Statistical analysis</title><p>Linear models with different slopes and intercepts for each genotype were used to compare the effect of genotype on <italic>INK4/ARF</italic> transcripts adjusting for age. ANOVA and Kruskal-Wallis tests were used to compare the mean gene expression across the genotypes (<xref ref-type="supplementary-material" rid="pone.0005027.s002">Table S2</xref>). A Student's t-test was used to compute p-values for the pair-wise comparisons between the genotypes, and p-values were adjusted using Bonferroni method for multiple comparisons (<xref ref-type="supplementary-material" rid="pone.0005027.s002">Table S2</xref>). All analysis was performed using SAS (v. 9.1.3, SAS Institute Inc).</p></sec></sec><sec id="s3"><title>Results</title><p>We selected six SNPs for genotyping based on strength of association in previous studies: two associated with atherosclerosis (rs10757278 and rs518394) <xref ref-type="bibr" rid="pone.0005027-Helgadottir1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-McPherson1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-The1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Samani1">&#x0005b;4&#x0005d;</xref>, two with T2DM (rs10811661 and rs564398) <xref ref-type="bibr" rid="pone.0005027-Scott1">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Saxena1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Zeggini1">&#x0005b;10&#x0005d;</xref>, one with frailty (rs2811712) <xref ref-type="bibr" rid="pone.0005027-Melzer1">&#x0005b;16&#x0005d;</xref>, and one with melanoma (rs11515, in the 3&#x02032; UTR of <italic>p16<sup>INK4a</sup></italic> and <italic>ARF</italic>)<xref ref-type="bibr" rid="pone.0005027-Kumar1">&#x0005b;17&#x0005d;</xref> (<xref ref-type="fig" rid="pone-0005027-g001">Fig. 1</xref>). These SNPs were also chosen to have limited LD across the locus (<xref ref-type="fig" rid="pone-0005027-g001">Fig. 1</xref> and <xref ref-type="supplementary-material" rid="pone.0005027.s001">Table S1</xref>). While no significant associations were noted between expression of any 9p21 transcript and five of the six SNPs analyzed (not shown), a strong association was noted between <italic>INK4/ARF</italic> transcript expression (log<sub>2</sub>-transformed or &#x00394;&#x00394;C<sub>T</sub>) and rs10757278 genotype (<xref ref-type="fig" rid="pone-0005027-g002">Fig. 2</xref> and <xref ref-type="supplementary-material" rid="pone.0005027.s002">Table S2</xref>). This SNP and nearby SNPs in high LD have been reproducibly associated with atherosclerotic disease in independent studies <xref ref-type="bibr" rid="pone.0005027-Helgadottir1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-McPherson1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-The1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Samani1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Helgadottir2">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Matarin1">&#x0005b;7&#x0005d;</xref>.</p><fig id="pone-0005027-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005027.g002</object-id><label>Figure 2</label><caption><title>Reduced transcription of the <italic>INK4/ARF</italic> locus is associated with the atherosclerosis risk allele of rs10757278.</title><p>(A) The risk allele (G) of rs10757278 is associated with reduced transcription of all four <italic>INK4/ARF</italic>-associated transcripts. Adjusted p-values (t-test) comparing mean AA vs. GG expression are shown: &#x0002a;p&#x0003c;0.001; &#x0002a;&#x0002a;p&#x0003c;0.0005; &#x0002a;&#x0002a;&#x0002a;p&#x0003c;0.0001. See also <xref ref-type="supplementary-material" rid="pone.0005027.s002">Table S2</xref> for details of ANOVA and Kruskal-Wallis comparisons. Error bars indicate SEM. (B) Expression of genes within <italic>INK4/ARF</italic> locus is associated with the risk allele of rs10757278 throughout chronological age. &#x0002a;p&#x0003c;0.01 for overall slope comparison; intercepts are not compared due to significant difference in slopes. &#x0002a;&#x0002a;p&#x0003e;0.05 for overall slope comparison and p&#x0003c;0.0001 for overall intercept comparison.</p></caption><graphic xlink:href="pone.0005027.g002"/></fig><p>We observed significantly reduced expression of <italic>ARF</italic>, <italic>p15<sup>INK4b</sup></italic>, <italic>p16<sup>INK4a</sup></italic>, and <italic>ANRIL</italic> in GG vs. AA individuals (<xref ref-type="fig" rid="pone-0005027-g002">Fig. 2A and 2B</xref>). The increase in expression in AA vs. GG donors was 2.1 to 2.8-fold for all four <italic>INK4/ARF</italic> transcripts, with an intermediate effect seen in AG individuals for each transcript. These effects were highly significant after adjustment for multiple comparisons (p&#x0003c;0.0001, <xref ref-type="supplementary-material" rid="pone.0005027.s002">Table S2</xref>). While expression of <italic>p16<sup>INK4a</sup></italic> is highly dynamic in PBTL with age, differences between genotypes were significant at all ages (<xref ref-type="fig" rid="pone-0005027-g002">Fig. 2B</xref>). Moreover, the <italic>p16<sup>INK4a</sup></italic> and <italic>ARF</italic> have two shared exons (<xref ref-type="fig" rid="pone-0005027-g001">Fig. 1</xref>, reviewed in <xref ref-type="bibr" rid="pone.0005027-Kim1">&#x0005b;12&#x0005d;</xref>), and aggregate <italic>p16<sup>INK4a</sup>/ARF</italic> expression detected with primers/probe pairs that span the shared exons (Exon2/3) were also significantly increased in AA individuals compared to GG individuals (<xref ref-type="fig" rid="pone-0005027-g002">Fig. 2A</xref>). In contrast, expression of a more distant 9p21 transcript, <italic>MTAP</italic>, as well as genes located on other chromosomes (<italic>p21<sup>CIP</sup></italic> and <italic>IRF8</italic>) was not associated with rs10757278 genotype (<xref ref-type="fig" rid="pone-0005027-g002">Fig. 2A</xref>). As the G-allele correlates with increased risk of atherosclerotic disease <xref ref-type="bibr" rid="pone.0005027-Helgadottir2">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Helgadottir3">&#x0005b;18&#x0005d;</xref>, these data indicate that decreased expression of all members of the <italic>INK4/ARF</italic> locus in PBTL is associated with a higher risk of atherosclerotic disease.</p></sec><sec id="s4"><title>Discussion</title><p>Here, we show that the expression of <italic>INK4/ARF</italic> locus transcripts is significantly reduced in individuals harboring a common allele of a 9p21 SNP &#x0223c;120 kb from the <italic>INK4a/ARF</italic> locus. This observation suggests a surprising human heterogeneity in the expression of genes that have been associated with various aspects of mammalian cancer and aging (reviewed in <xref ref-type="bibr" rid="pone.0005027-Sharpless1">&#x0005b;19&#x0005d;</xref>), including a particular importance in lymphocyte aging <xref ref-type="bibr" rid="pone.0005027-Signer1">&#x0005b;20&#x0005d;</xref>. We believe this observation can be most parsimoniously explained by the existence of a polymorphic cis-regulatory element that influences expression of the <italic>INK4/ARF</italic> locus and that is closely linked to rs10757278. Cis-regulatory element located more than 100 kb apart from affected open reading frames (ORFs) are well-described at other loci <xref ref-type="bibr" rid="pone.0005027-Kleinjan1">&#x0005b;21&#x0005d;</xref>.</p><p>It is important to note that rs10757278 and linked SNPs in high LD (e.g. rs1333049) are associated with family history of atherosclerotic disease, but not other traditional risk factors including body mass index, diabetes, tobacco use, blood pressure, C-reactive protein or lipid levels <xref ref-type="bibr" rid="pone.0005027-McPherson1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Schunkert1">&#x0005b;22&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Paynter1">&#x0005b;23&#x0005d;</xref>. The risk genotypes, however, are strongly associated with coronary artery calcification, premature atherosclerosis and angiographically characterized disease <xref ref-type="bibr" rid="pone.0005027-McPherson1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Anderson1">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Muendlein1">&#x0005b;25&#x0005d;</xref>. Therefore, we believe the present finding supports a direct link between <italic>INK4/ARF</italic> expression and atherogenesis.</p><p>We believe a reasonable argument can be made for how each of the <italic>INK4/ARF</italic> transcripts might modulate the earliest stages of atherosclerosis. The INK4-class cyclin dependent kinase (CDK) inhibitors, of which p15<sup>INK4b</sup> and p16<sup>INK4a</sup> are founding members, block cell cycle progression by inhibiting the activity of the proliferative kinases CDK4 and CDK6. A role for cell cycle inhibitors has been postulated in promoting favorable vascular remodeling and preventing pathologic intimal hyperplasia by regulating G1 to S phase progression in vascular smooth muscle cells (reviewed in <xref ref-type="bibr" rid="pone.0005027-Boehm1">&#x0005b;26&#x0005d;</xref>). In support of this notion, mice lacking p16<sup>INK4a</sup> have been shown to be more sensitive to vascular intimal hyperplasia in a carotid artery injury model <xref ref-type="bibr" rid="pone.0005027-Gizard1">&#x0005b;27&#x0005d;</xref>, suggesting that p16<sup>INK4a</sup> protects against atherogenesis by limiting a pathologic vascular reaction to injury in some circumstances. Likewise, TGF-&#x003b2; signaling is thought to attenuate atherogenesis <xref ref-type="bibr" rid="pone.0005027-Kalinina1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Grainger1">29</xref>, and the anti-proliferative effects of TGF-&#x003b2; signaling are in part mediated by p15<sup>INK4b</sup> (ref. <xref ref-type="bibr" rid="pone.0005027-Reynisdottir1">&#x0005b;30&#x0005d;</xref>). ARF, on the other hand, inhibits the cell cycle by activating the p53 tumor suppressor. In murine systems, Arf expression and has been shown to exert a general anti-aging effect <xref ref-type="bibr" rid="pone.0005027-Matheu1">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Baker1">&#x0005b;32&#x0005d;</xref>, presumably through an enhancement of DNA repair. Likewise, Arf expression has been shown to play a specific role in vascular biology in the development of the murine eye <xref ref-type="bibr" rid="pone.0005027-McKeller1">&#x0005b;33&#x0005d;</xref>. Together, expression of p15<sup>INK4b</sup>, p16<sup>INK4a</sup> or ARF, either alone or in combination could plausibly retard atherogenesis, most likely by limiting pathogenic vascular proliferation.</p><p>As the putative non-coding RNA <italic>ANRIL</italic> spans the risk-associated SNPs, <italic>ANRIL</italic> might be directly affected by the unknown causative genetic variant in strong LD with rs10757278. Importantly, Polycomb group (PcG) complexes potently repress <italic>INK4/ARF</italic> locus expression <xref ref-type="bibr" rid="pone.0005027-Kotake1">&#x0005b;34&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Bracken1">&#x0005b;35&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-He1">&#x0005b;36&#x0005d;</xref>, and cis-acting non-coding RNAs have been shown to play an important role in PcG-mediated repression at other loci (e.g. <italic>Xist</italic> at the inactive X-chromosome, reviewed in <xref ref-type="bibr" rid="pone.0005027-Ng1">&#x0005b;37&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Wutz1">&#x0005b;38&#x0005d;</xref>). Therefore, it is possible that altered <italic>ANRIL</italic> expression could potentially regulate <italic>INK4/ARF</italic> repression through PcG complexes, explaining why all four <italic>INK4/ARF</italic> transcripts are coordinately associated with rs10757278 genotype. On the other hand, <italic>ANRIL</italic> could also influence the expression of other genes in trans- as has been recently reported for <italic>HOTAIR</italic> at <italic>Hox</italic> loci <xref ref-type="bibr" rid="pone.0005027-Rinn1">&#x0005b;39&#x0005d;</xref>.</p><p>Importantly, however, it is likely the effects of <italic>INK4/ARF</italic> expression on the development of atherosclerosis do not result from their expression in PBTL, but rather, observations in PBTL may serve as a surrogate for <italic>INK4/ARF</italic> expression in other tissues. As cis-regulatory elements may act as enhancers in one tissue and repressors in another, it is also possible that genetic variants in LD with rs10757278 genotype might be associated with increased <italic>INK4/ARF</italic> transcript expression in other tissues of greater relevance to atherogenesis (e.g. endothelial progenitors or vascular smooth muscle cells). Several investigators have argued that cellular senescence, which is induced by p16<sup>INK4a</sup>, promotes atherosclerosis (e.g. <xref ref-type="bibr" rid="pone.0005027-Matthews1">&#x0005b;40&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005027-Rauscher1">&#x0005b;41&#x0005d;</xref>), and we do not believe the present results are necessarily inconsistent with that view. Carefully designed murine studies will serve to elucidate the effects of <italic>INK4/ARF</italic> expression on atherogenesis.</p><p>In summary, our data suggests that a common genetic variant in strong LD with rs10757278 at chromosome 9p21 influences the expression of the <italic>INK4/ARF</italic>-associated transcripts, but not <italic>MTAP</italic>, in PBTL. These observations provocatively suggest a crucial role for cell cycle inhibition in the development of atherosclerotic disease in humans.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0005027.s001"><label>Table S1</label><caption><p>(2.37 MB TIF)</p></caption><media xlink:href="pone.0005027.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005027.s002"><label>Table S2</label><caption><p>(2.42 MB TIF)</p></caption><media xlink:href="pone.0005027.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors would like to thank C. Patterson, J. Cohen, and T. Rosenzweig for critical reading of the manuscript; P. Dillon for assistance with subject accrual; and K. Janakiraman for technical advice.</p></ack><ref-list><title>References</title><ref id="pone.0005027-Helgadottir1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Helgadottir</surname><given-names>A</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Manolescu</surname><given-names>A</given-names></name><name><surname>Gretarsdottir</surname><given-names>S</given-names></name><name><surname>Blondal</surname><given-names>T</given-names></name><etal/></person-group><year>2007</year><article-title>A common variant on chromosome 9p21 affects the risk of myocardial infarction.</article-title><source>Science</source><volume>316</volume><fpage>1491</fpage><lpage>1493</lpage><pub-id pub-id-type="pmid">17478679</pub-id></citation></ref><ref id="pone.0005027-McPherson1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McPherson</surname><given-names>R</given-names></name><name><surname>Pertsemlidis</surname><given-names>A</given-names></name><name><surname>Kavaslar</surname><given-names>N</given-names></name><name><surname>Stewart</surname><given-names>A</given-names></name><name><surname>Roberts</surname><given-names>R</given-names></name><etal/></person-group><year>2007</year><article-title>A common allele on chromosome 9 associated with coronary heart disease.</article-title><source>Science</source><volume>316</volume><fpage>1488</fpage><lpage>1491</lpage><pub-id pub-id-type="pmid">17478681</pub-id></citation></ref><ref id="pone.0005027-The1"><label>3</label><citation citation-type="journal"><collab>The Wellcome Trust Case Control Consortium</collab><year>2007</year><article-title>Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.</article-title><source>Nature</source><volume>447</volume><fpage>661</fpage><lpage>678</lpage><pub-id pub-id-type="pmid">17554300</pub-id></citation></ref><ref id="pone.0005027-Samani1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Samani</surname><given-names>NJ</given-names></name><name><surname>Erdmann</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>AS</given-names></name><name><surname>Hengstenberg</surname><given-names>C</given-names></name><name><surname>Mangino</surname><given-names>M</given-names></name><etal/></person-group><year>2007</year><article-title>Genomewide association analysis of coronary artery disease.</article-title><source>N Engl J Med</source><volume>357</volume><fpage>443</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">17634449</pub-id></citation></ref><ref id="pone.0005027-Broadbent1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Broadbent</surname><given-names>HM</given-names></name><name><surname>Peden</surname><given-names>JF</given-names></name><name><surname>Lorkowski</surname><given-names>S</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><name><surname>Ongen</surname><given-names>H</given-names></name><etal/></person-group><year>2008</year><article-title>Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p.</article-title><source>Hum Mol Genet</source><volume>17</volume><fpage>806</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">18048406</pub-id></citation></ref><ref id="pone.0005027-Helgadottir2"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Helgadottir</surname><given-names>A</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Magnusson</surname><given-names>KP</given-names></name><name><surname>Gretarsdottir</surname><given-names>S</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><etal/></person-group><year>2008</year><article-title>The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm.</article-title><source>Nat Genet</source><volume>40</volume><fpage>217</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">18176561</pub-id></citation></ref><ref id="pone.0005027-Matarin1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matarin</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>WM</given-names></name><name><surname>Singleton</surname><given-names>A</given-names></name><name><surname>Hardy</surname><given-names>JA</given-names></name><name><surname>Meschia</surname><given-names>JF</given-names></name></person-group><year>2008</year><article-title>Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21.</article-title><source>Stroke</source><volume>39</volume><fpage>1586</fpage><lpage>1589</lpage><pub-id pub-id-type="pmid">18340101</pub-id></citation></ref><ref id="pone.0005027-Scott1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Bonnycastle</surname><given-names>LL</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><year>2007</year><article-title>A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.</article-title><source>Science</source><volume>316</volume><fpage>1341</fpage><lpage>1345</lpage><pub-id pub-id-type="pmid">17463248</pub-id></citation></ref><ref id="pone.0005027-Saxena1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Burtt</surname><given-names>NP</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name><etal/></person-group><year>2007</year><article-title>Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.</article-title><source>Science</source><volume>316</volume><fpage>1331</fpage><lpage>1336</lpage><pub-id pub-id-type="pmid">17463246</pub-id></citation></ref><ref id="pone.0005027-Zeggini1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Elliott</surname><given-names>KS</given-names></name><etal/></person-group><year>2007</year><article-title>Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.</article-title><source>Science</source><volume>316</volume><fpage>1336</fpage><lpage>1341</lpage><pub-id pub-id-type="pmid">17463249</pub-id></citation></ref><ref id="pone.0005027-Krishnamurthy1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurthy</surname><given-names>J</given-names></name><name><surname>Ramsey</surname><given-names>MR</given-names></name><name><surname>Ligon</surname><given-names>KL</given-names></name><name><surname>Torrice</surname><given-names>C</given-names></name><name><surname>Koh</surname><given-names>A</given-names></name><etal/></person-group><year>2006</year><article-title>p16INK4a induces an age-dependent decline in islet regenerative potential.</article-title><source>Nature</source><volume>443</volume><fpage>453</fpage><lpage>457</lpage><pub-id pub-id-type="pmid">16957737</pub-id></citation></ref><ref id="pone.0005027-Kim1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>WY</given-names></name><name><surname>Sharpless</surname><given-names>NE</given-names></name></person-group><year>2006</year><article-title>The regulation of INK4/ARF in cancer and aging.</article-title><source>Cell</source><volume>127</volume><fpage>265</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">17055429</pub-id></citation></ref><ref id="pone.0005027-Pasmant1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pasmant</surname><given-names>E</given-names></name><name><surname>Laurendeau</surname><given-names>I</given-names></name><name><surname>Heron</surname><given-names>D</given-names></name><name><surname>Vidaud</surname><given-names>M</given-names></name><name><surname>Vidaud</surname><given-names>D</given-names></name><etal/></person-group><year>2007</year><article-title>Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF.</article-title><source>Cancer Res</source><volume>67</volume><fpage>3963</fpage><lpage>3969</lpage><pub-id pub-id-type="pmid">17440112</pub-id></citation></ref><ref id="pone.0005027-Shields1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shields</surname><given-names>JM</given-names></name><name><surname>Thomas</surname><given-names>NE</given-names></name><name><surname>Cregger</surname><given-names>M</given-names></name><name><surname>Berger</surname><given-names>AJ</given-names></name><name><surname>Leslie</surname><given-names>M</given-names></name><etal/></person-group><year>2007</year><article-title>Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma.</article-title><source>Cancer Res</source><volume>67</volume><fpage>1502</fpage><lpage>1512</lpage><pub-id pub-id-type="pmid">17308088</pub-id></citation></ref><ref id="pone.0005027-Livak1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><year>2001</year><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">11846609</pub-id></citation></ref><ref id="pone.0005027-Melzer1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melzer</surname><given-names>D</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Murray</surname><given-names>A</given-names></name><name><surname>Hurst</surname><given-names>AJ</given-names></name><name><surname>Harries</surname><given-names>LW</given-names></name><etal/></person-group><year>2007</year><article-title>A common variant of the p16(INK4a) genetic region is associated with physical function in older people.</article-title><source>Mech Ageing Dev</source><volume>128</volume><fpage>370</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">17459456</pub-id></citation></ref><ref id="pone.0005027-Kumar1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Smeds</surname><given-names>J</given-names></name><name><surname>Berggren</surname><given-names>P</given-names></name><name><surname>Straume</surname><given-names>O</given-names></name><name><surname>Rozell</surname><given-names>BL</given-names></name><etal/></person-group><year>2001</year><article-title>A single nucleotide polymorphism in the 3&#x02032;untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare.</article-title><source>Int J Cancer</source><volume>95</volume><fpage>388</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">11668523</pub-id></citation></ref><ref id="pone.0005027-Helgadottir3"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Helgadottir</surname><given-names>A</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Manolescu</surname><given-names>A</given-names></name><name><surname>Gretarsdottir</surname><given-names>S</given-names></name><name><surname>Blondal</surname><given-names>T</given-names></name><etal/></person-group><year>2007</year><article-title>A common variant on chromosome 9p21 affects the risk of myocardial infarction.</article-title><source>Science</source><volume>316</volume><fpage>1491</fpage><lpage>1493</lpage><pub-id pub-id-type="pmid">17478679</pub-id></citation></ref><ref id="pone.0005027-Sharpless1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharpless</surname><given-names>NE</given-names></name><name><surname>DePinho</surname><given-names>RA</given-names></name></person-group><year>2007</year><article-title>How stem cells age and why this makes us grow old.</article-title><source>Nat Rev Mol Cell Biol</source><volume>8</volume><fpage>703</fpage><lpage>713</lpage><pub-id pub-id-type="pmid">17717515</pub-id></citation></ref><ref id="pone.0005027-Signer1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Signer</surname><given-names>RA</given-names></name><name><surname>Montecino-Rodriguez</surname><given-names>E</given-names></name><name><surname>Witte</surname><given-names>ON</given-names></name><name><surname>Dorshkind</surname><given-names>K</given-names></name></person-group><year>2008</year><article-title>Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16Ink4a and Arf.</article-title><source>Genes Dev</source><volume>22</volume><fpage>3115</fpage><lpage>3120</lpage><pub-id pub-id-type="pmid">19056891</pub-id></citation></ref><ref id="pone.0005027-Kleinjan1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kleinjan</surname><given-names>DA</given-names></name><name><surname>van Heyningen</surname><given-names>V</given-names></name></person-group><year>2005</year><article-title>Long-range control of gene expression: emerging mechanisms and disruption in disease.</article-title><source>Am J Hum Genet</source><volume>76</volume><fpage>8</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">15549674</pub-id></citation></ref><ref id="pone.0005027-Schunkert1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schunkert</surname><given-names>H</given-names></name><name><surname>Gotz</surname><given-names>A</given-names></name><name><surname>Braund</surname><given-names>P</given-names></name><name><surname>McGinnis</surname><given-names>R</given-names></name><name><surname>Tregouet</surname><given-names>DA</given-names></name><etal/></person-group><year>2008</year><article-title>Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease.</article-title><source>Circulation</source><volume>117</volume><fpage>1675</fpage><lpage>1684</lpage><pub-id pub-id-type="pmid">18362232</pub-id></citation></ref><ref id="pone.0005027-Paynter1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paynter</surname><given-names>NP</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><name><surname>Shiffman</surname><given-names>D</given-names></name><name><surname>Cook</surname><given-names>NR</given-names></name><etal/></person-group><year>2009</year><article-title>Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3.</article-title><source>Ann Intern Med</source><volume>150</volume><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">19153409</pub-id></citation></ref><ref id="pone.0005027-Anderson1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JL</given-names></name><name><surname>Horne</surname><given-names>BD</given-names></name><name><surname>Kolek</surname><given-names>MJ</given-names></name><name><surname>Muhlestein</surname><given-names>JB</given-names></name><name><surname>Mower</surname><given-names>CP</given-names></name><etal/></person-group><year>2008</year><article-title>Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility.</article-title><source>Am Heart J</source><volume>156</volume><fpage>1155</fpage><lpage>1162 e1152</lpage><pub-id pub-id-type="pmid">19033013</pub-id></citation></ref><ref id="pone.0005027-Muendlein1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muendlein</surname><given-names>A</given-names></name><name><surname>Saely</surname><given-names>CH</given-names></name><name><surname>Rhomberg</surname><given-names>S</given-names></name><name><surname>Sonderegger</surname><given-names>G</given-names></name><name><surname>Loacker</surname><given-names>S</given-names></name><etal/></person-group><year>2008</year><article-title>Evaluation of the association of genetic variants on the chromosomal loci 9p21.3, 6q25.1, and 2q36.3 with angiographically characterized coronary artery disease.</article-title><source>Atherosclerosis</source><comment>In Press</comment></citation></ref><ref id="pone.0005027-Boehm1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boehm</surname><given-names>M</given-names></name><name><surname>Nabel</surname><given-names>EG</given-names></name></person-group><year>2003</year><article-title>The cell cycle and cardiovascular diseases.</article-title><source>Prog Cell Cycle Res</source><volume>5</volume><fpage>19</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">14593697</pub-id></citation></ref><ref id="pone.0005027-Gizard1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gizard</surname><given-names>F</given-names></name><name><surname>Amant</surname><given-names>C</given-names></name><name><surname>Barbier</surname><given-names>O</given-names></name><name><surname>Bellosta</surname><given-names>S</given-names></name><name><surname>Robillard</surname><given-names>R</given-names></name><etal/></person-group><year>2005</year><article-title>PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.</article-title><source>J Clin Invest</source><volume>115</volume><fpage>3228</fpage><lpage>3238</lpage><pub-id pub-id-type="pmid">16239970</pub-id></citation></ref><ref id="pone.0005027-Kalinina1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalinina</surname><given-names>N</given-names></name><name><surname>Agrotis</surname><given-names>A</given-names></name><name><surname>Antropova</surname><given-names>Y</given-names></name><name><surname>Ilyinskaya</surname><given-names>O</given-names></name><name><surname>Smirnov</surname><given-names>V</given-names></name><etal/></person-group><year>2004</year><article-title>Smad Expression in Human Atherosclerotic Lesions: Evidence for Impaired TGF-{beta}/Smad Signaling in Smooth Muscle Cells of Fibrofatty Lesions.</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>24</volume><fpage>1391</fpage><lpage>1396</lpage><pub-id pub-id-type="pmid">15166010</pub-id></citation></ref><ref id="pone.0005027-Grainger1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grainger</surname><given-names>DJ</given-names></name></person-group><year>2004</year><article-title>Transforming growth factor {beta} and atherosclerosis: so far, so good for the protective cytokine hypothesis.</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>24</volume><fpage>399</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">14699019</pub-id></citation></ref><ref id="pone.0005027-Reynisdottir1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reynisdottir</surname><given-names>I</given-names></name><name><surname>Polyak</surname><given-names>K</given-names></name><name><surname>Iavarone</surname><given-names>A</given-names></name><name><surname>Massague</surname><given-names>J</given-names></name></person-group><year>1995</year><article-title>Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.</article-title><source>Genes Dev</source><volume>9</volume><fpage>1831</fpage><lpage>1845</lpage><pub-id pub-id-type="pmid">7649471</pub-id></citation></ref><ref id="pone.0005027-Matheu1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matheu</surname><given-names>A</given-names></name><name><surname>Maraver</surname><given-names>A</given-names></name><name><surname>Klatt</surname><given-names>P</given-names></name><name><surname>Flores</surname><given-names>I</given-names></name><name><surname>Garcia-Cao</surname><given-names>I</given-names></name><etal/></person-group><year>2007</year><article-title>Delayed ageing through damage protection by the Arf/p53 pathway.</article-title><source>Nature</source><volume>448</volume><fpage>375</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">17637672</pub-id></citation></ref><ref id="pone.0005027-Baker1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>DJ</given-names></name><name><surname>Perez-Terzic</surname><given-names>C</given-names></name><name><surname>Jin</surname><given-names>F</given-names></name><name><surname>Pitel</surname><given-names>K</given-names></name><name><surname>Niederlander</surname><given-names>NJ</given-names></name><etal/></person-group><year>2008</year><article-title>Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency.</article-title><source>Nat Cell Biol</source><volume>10</volume><fpage>825</fpage><lpage>836</lpage><pub-id pub-id-type="pmid">18516091</pub-id></citation></ref><ref id="pone.0005027-McKeller1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McKeller</surname><given-names>RN</given-names></name><name><surname>Fowler</surname><given-names>JL</given-names></name><name><surname>Cunningham</surname><given-names>JJ</given-names></name><name><surname>Warner</surname><given-names>N</given-names></name><name><surname>Smeyne</surname><given-names>RJ</given-names></name><etal/></person-group><year>2002</year><article-title>The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development.</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>99</volume><fpage>3848</fpage><lpage>3853</lpage><pub-id pub-id-type="pmid">11891301</pub-id></citation></ref><ref id="pone.0005027-Kotake1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kotake</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>R</given-names></name><name><surname>Viatour</surname><given-names>P</given-names></name><name><surname>Sage</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><year>2007</year><article-title>pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.</article-title><source>Genes Dev</source><volume>21</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">17210787</pub-id></citation></ref><ref id="pone.0005027-Bracken1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bracken</surname><given-names>AP</given-names></name><name><surname>Kleine-Kohlbrecher</surname><given-names>D</given-names></name><name><surname>Dietrich</surname><given-names>N</given-names></name><name><surname>Pasini</surname><given-names>D</given-names></name><name><surname>Gargiulo</surname><given-names>G</given-names></name><etal/></person-group><year>2007</year><article-title>The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells.</article-title><source>Genes Dev</source><volume>21</volume><fpage>525</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">17344414</pub-id></citation></ref><ref id="pone.0005027-He1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>J</given-names></name><name><surname>Kallin</surname><given-names>EM</given-names></name><name><surname>Tsukada</surname><given-names>Y-i</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year>2008</year><article-title>The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15Ink4b.</article-title><source>Nat Struct Mol Biol</source><volume>15</volume><fpage>1169</fpage><lpage>1175</lpage><pub-id pub-id-type="pmid">18836456</pub-id></citation></ref><ref id="pone.0005027-Ng1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>K</given-names></name><name><surname>Pullirsch</surname><given-names>D</given-names></name><name><surname>Leeb</surname><given-names>M</given-names></name><name><surname>Wutz</surname><given-names>A</given-names></name></person-group><year>2007</year><article-title>Xist and the order of silencing.</article-title><source>EMBO Rep</source><volume>8</volume><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">17203100</pub-id></citation></ref><ref id="pone.0005027-Wutz1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wutz</surname><given-names>A</given-names></name></person-group><year>2007</year><article-title>Xist function: bridging chromatin and stem cells.</article-title><source>Trends Genet</source><volume>23</volume><fpage>457</fpage><lpage>464</lpage><pub-id pub-id-type="pmid">17681633</pub-id></citation></ref><ref id="pone.0005027-Rinn1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rinn</surname><given-names>JL</given-names></name><name><surname>Kertesz</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>JK</given-names></name><name><surname>Squazzo</surname><given-names>SL</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><etal/></person-group><year>2007</year><article-title>Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs.</article-title><source>Cell</source><volume>129</volume><fpage>1311</fpage><lpage>1323</lpage><pub-id pub-id-type="pmid">17604720</pub-id></citation></ref><ref id="pone.0005027-Matthews1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>C</given-names></name><name><surname>Gorenne</surname><given-names>I</given-names></name><name><surname>Scott</surname><given-names>S</given-names></name><name><surname>Figg</surname><given-names>N</given-names></name><name><surname>Kirkpatrick</surname><given-names>P</given-names></name><etal/></person-group><year>2006</year><article-title>Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress.</article-title><source>Circ Res</source><volume>99</volume><fpage>156</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">16794190</pub-id></citation></ref><ref id="pone.0005027-Rauscher1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rauscher</surname><given-names>FM</given-names></name><name><surname>Goldschmidt-Clermont</surname><given-names>PJ</given-names></name><name><surname>Davis</surname><given-names>BH</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Gregg</surname><given-names>D</given-names></name><etal/></person-group><year>2003</year><article-title>Aging, progenitor cell exhaustion, and atherosclerosis.</article-title><source>Circulation</source><volume>108</volume><fpage>457</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">12860902</pub-id></citation></ref><ref id="pone.0005027-The2"><label>42</label><citation citation-type="journal"><collab>The International HapMap C</collab><year>2005</year><article-title>A haplotype map of the human genome.</article-title><source>Nature</source><volume>437</volume><fpage>1299</fpage><lpage>1320</lpage><pub-id pub-id-type="pmid">16255080</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported by grants from the NIH (RR023248, AG024379, DK072193), the Ellison Medical Foundation and the Burroughs Wellcome Fund. Y.L. is supported by NIH training grant CA009156-34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 